FDA Approves AnaptysBio-Discovered Drug for Rectal Cancer
The FDA granted accelerated approval to Jempezi, a drug discovered by AnaptysBio. Shares gained 5.8% to $49.31 in Monday afternoon trading.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.